↓ Skip to main content

Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?

Overview of attention for article published in Clinical and Applied Thrombosis/Hemostasis, January 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Should Low-Molecular-Weight Heparin be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism?
Published in
Clinical and Applied Thrombosis/Hemostasis, January 2015
DOI 10.1177/1076029614564863
Pubmed ID
Authors

Aysegul Senturk, Elif Yilmazel Ucar, Serdar Berk, Tevfik Ozlu, Bulent Altınsoy, Gul Dabak, Ebru Cakır, Esra Ekbic Kadıoglu, Hadice Selimoglu Sen, Savas Ozsu

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 23%
Student > Bachelor 2 15%
Student > Master 2 15%
Professor 1 8%
Professor > Associate Professor 1 8%
Other 1 8%
Unknown 3 23%
Readers by discipline Count As %
Medicine and Dentistry 5 38%
Biochemistry, Genetics and Molecular Biology 2 15%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Engineering 1 8%
Unknown 4 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2019.
All research outputs
#9,118,500
of 14,521,855 outputs
Outputs from Clinical and Applied Thrombosis/Hemostasis
#199
of 441 outputs
Outputs of similar age
#186,255
of 309,937 outputs
Outputs of similar age from Clinical and Applied Thrombosis/Hemostasis
#1
of 1 outputs
Altmetric has tracked 14,521,855 research outputs across all sources so far. This one is in the 24th percentile – i.e., 24% of other outputs scored the same or lower than it.
So far Altmetric has tracked 441 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,937 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them